An additional dose of cefazolin for intraoperative prophylaxis

Area of Science:

• Pharmacology
• Surgical Infectious Diseases
• Clinical Microbiology

Background:

• Cefazolin is a common antibiotic used in surgical prophylaxis.
• Optimal dosing strategies are crucial for maintaining effective drug concentrations at surgical sites, particularly in pancreatic surgery.
• Pancreatic tissue antibiotic levels can be influenced by patient factors and surgical conditions.

Purpose of the Study:

• To determine pancreatic tissue concentrations of cefazolin after a single dose.
• To identify the optimal time for a repeat cefazolin dose during pancreatectomy.
• To assess cefazolin's efficacy against common bacterial pathogens in surgical site infections.

Main Methods:

• Ten patients undergoing pancreatectomy received a 1g intravenous cefazolin dose.
• Peripheral blood, adipose tissue, peritoneal, and pancreatic tissue samples were collected hourly for 4 hours.
• Antibiotic concentrations were measured and compared to minimum inhibitory concentrations (MIC80) for Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, and Streptococcus spp.

Main Results:

• Adipose and peritoneal cefazolin concentrations at 3 hours were below MIC80 for K. pneumoniae, E. coli, and Streptococcus spp.
• Most pancreatic tissue concentrations exceeded MIC80 for these bacteria.
• Four patients with severe chronic pancreatitis, bleeding, or obesity had lower-than-adequate pancreatic cefazolin levels.

Conclusions:

• A second cefazolin dose administered 3 hours after the initial dose is recommended.
• This dosing strategy aims to maintain adequate antibiotic activity in pancreatic tissue.
• Consideration of patient-specific factors like obesity and comorbidities is essential for effective cefazolin prophylaxis.